Cargando…

Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy

BACKGROUND: Recently a prognostic score that predicts 12-month survival in patients treated with fractionated radiotherapy for painful bone metastases has been developed. Fractionated radiotherapy might cause unnecessary burden for patients with limited survival, thus estimation of survival is clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieder, Carsten, Mannsaker, Bard, Dalhaug, Astrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011938/ https://www.ncbi.nlm.nih.gov/pubmed/32095178 http://dx.doi.org/10.14740/jocmr4060

Ejemplares similares

Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
por: Nieder, Carsten, et al.
Publicado: (2023)

The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Percent of remaining life on palliative radiation treatment: solely a function of fractionation?
por: Nieder, Carsten, et al.
Publicado: (2023)

External Validation of the LabBM Score in Patients With Brain Metastases
por: Nieder, Carsten, et al.
Publicado: (2019)

Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance
por: Nieder, Carsten, et al.
Publicado: (2017)

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013)

Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison
por: Nieder, Carsten, et al.
Publicado: (2015)

The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2021)

Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis
por: Nieder, Carsten, et al.
Publicado: (2022)

Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019)

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
por: Nieder, Carsten, et al.
Publicado: (2012)

Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy
por: Angelo, Kent, et al.
Publicado: (2014)

Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
por: Nieder, Carsten, et al.
Publicado: (2022)

Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels
por: Nieder, Carsten, et al.
Publicado: (2012)

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2020)

Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery
por: Nieder, Carsten, et al.
Publicado: (2018)

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2012)

A Case of Five-Year Survival After Combined-Modality Treatment for Non-Small Cell Lung Cancer With Intraspinal Metastasis
por: Nieder, Carsten, et al.
Publicado: (2022)

Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival Outcome
por: Nieder, Carsten, et al.
Publicado: (2020)

Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Contribution of Case Reports to Brain Metastases Research: Systematic Review and Analysis of Pattern of Citation
por: Nieder, Carsten, et al.
Publicado: (2012)

Continuous controversy about radiation oncologists’ choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?
por: Nieder, Carsten, et al.
Publicado: (2013)

External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors
por: Lewitzki, Victor, et al.
Publicado: (2019)

30-day mortality in patients treated for brain metastases: extracranial causes dominate
por: Nieder, Carsten, et al.
Publicado: (2022)

Palliative Radiotherapy with or without Additional Care by a Multidisciplinary Palliative Care Team: A Retrospective Comparison
por: Nieder, Carsten, et al.
Publicado: (2014)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

Presentation and course of brain metastases from breast cancer in a paranoid-schizophrenic patient: A case report
por: Dalhaug, Astrid, et al.
Publicado: (2008)

Second Re-irradiation: Clinical Examples of Worthwhile Treatment
por: Nieder, Carsten, et al.
Publicado: (2018)

Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer
por: Nieder, Carsten, et al.
Publicado: (2017)

Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?
por: Nieder, Carsten, et al.
Publicado: (2020)

Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain?
por: Nieder, Carsten, et al.
Publicado: (2008)

Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness
por: Yoon, Frederick, et al.
Publicado: (2014)

EXTERNAL BEAM RADIOTHERAPY FOR PAINFUL BONE METASTASES FROM HEPATOCELLULAR CARCINOMA: MULTIPLE FRACTIONS COMPARED WITH AN 8-GY SINGLE FRACTION
por: HAYASHI, SHINYA, et al.
Publicado: (2014)

Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?
por: Nieder, Carsten, et al.
Publicado: (2019)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
por: Herskind, Carsten, et al.
Publicado: (2017)

Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors
por: Nieder, Carsten, et al.
Publicado: (2023)

A New Survival Score for Patients ≥65 Years Assigned to Radiotherapy of Bone Metastases
por: Rades, Dirk, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_er1n7k6s0ltmju3tmel0a1v04p